TGA Approval

Nevirapine XR SPR nevirapine 400 mg modified release tablet blister pack (384183)

ARTG ID

384183

ARTG Name

Nevirapine XR SPR nevirapine 400 mg modified release tablet blister pack

Sponsor

Arrotex Pharmaceuticals Pty Ltd

ARTG Date

June 10, 2022

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Arrotex Pharmaceuticals Pty Ltd.

Ingredient Name

nevirapine

Empowering clinical research with data-driven insights and AI-powered tools.

Nevirapine XR SPR nevirapine 400 mg modified release tablet blister pack (384183) - TGA 批准文号 | MedPath